This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ISRG Expands Installed Base, But Is Utilization Keeping Pace?
by Indrajit Bandyopadhyay
Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.
SYKNegative Net Change ISRGPositive Net Change ZBHPositive Net Change
medical medical-devices
Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness
by Zacks Equity Research
HIMS is transforming digital wellness with personalized care, over 30 million telehealth consultations, and a Gen Z-aligned platform.
MEDNegative Net Change HIMSPositive Net Change LFMDNegative Net Change
medical medical-devices
Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial
by Zacks Equity Research
STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.
STXSPositive Net Change CORPositive Net Change ITGRPositive Net Change HIMSPositive Net Change
medical medical-devices
ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?
by Indrajit Bandyopadhyay
ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.
MDTPositive Net Change SYKNegative Net Change ISRGPositive Net Change
medical medical-devices
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?
by Zacks Equity Research
DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.
DGXPositive Net Change CAHPositive Net Change CORPositive Net Change PAHCPositive Net Change
medical medical-devices
Should You Buy WisdomTree, Inc. (WT) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vertiv Holdings Co. (VRT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
VRTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy WSFS Financial (WSFS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
WSFSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy 1st Source (SRCE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SRCEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
MSC Industrial (MSM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MSMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark
by Zacks Equity Research
ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.
ISRGPositive Net Change CORPositive Net Change ITGRPositive Net Change HIMSPositive Net Change
medical medical-devices
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
by Moumi Mondal
Strong pharmacy drug mix, flu season and store optimization power CVS Health's PCW gains. Will the momentum continue?
WMTNegative Net Change CVSNegative Net Change
medical medical-devices
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
by Urmimala Biswas
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
NTRAPositive Net Change GHPositive Net Change TEMPositive Net Change
artificial-intelligence medical medical-devices smart-health
Hims & Hers Enhances Healthcare Through AI-Driven Personalization
by Zacks Equity Research
HIMS taps AI and $870 million in funding to deliver smarter, more personalized healthcare through tech-driven innovation.
TDOCNegative Net Change HIMSPositive Net Change TEMPositive Net Change
medical medical-devices
Is Rigetti's Growth Model Too Dependent on Government Deals?
by Harshit Gupta
RGTI leans heavily on government contracts, but limited private traction clouds its commercial growth outlook.
IONQNegative Net Change RGTINegative Net Change QBTSNegative Net Change
medical medical-devices
Do Options Traders Know Something About Addus HomeCare Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ADUS stock based on the movements in the options market lately.
ADUSNegative Net Change
medical medical-devices
Should You Buy Hancock Whitney (HWC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
HWCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ionis Pharmaceuticals (IONS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
IONSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UBS (UBS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
UBSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
by Zacks Equity Research
TFX gains 2.9% after acquiring BIOTRONIK's vascular unit, boosting its cath lab presence and innovation pipeline.
BSXPositive Net Change TFXNegative Net Change CORPositive Net Change PAHCPositive Net Change
medical medical-devices
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
by Shrabana Mukherjee
These women-run company stocks offer high growth and stability.
ACNNegative Net Change MCKPositive Net Change ELPositive Net Change ADBEPositive Net Change CNCNegative Net Change BMBLNegative Net Change
healthcare internet medical medical-devices tech-stocks thematic
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
by Debanjana Dey
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
DGXPositive Net Change DVANegative Net Change EHCNegative Net Change PNTGNegative Net Change
medical medical-devices
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation
by Harshit Gupta
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
VEEVPositive Net Change IQVPositive Net Change SDGRPositive Net Change
medical medical-devices
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now
by Zacks Equity Research
HQY's sustained strength in HSAs raises optimism about the stock.
CORPositive Net Change HQYPositive Net Change ITGRPositive Net Change HIMSPositive Net Change
medical medical-devices
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion
by Zacks Equity Research
ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.
ABTNegative Net Change CORPositive Net Change PAHCPositive Net Change HIMSPositive Net Change
medical medical-devices